Likewise, the proportion of gp130+ cells did not differ significantly between the healthy controls and SLE patients in the lymphocyte subpopulations (Supplementary Figures 1A–C) i.e. CD3─CD4─ (p=0.701), CD3+CD4─ (p=0.080) and CD3+CD4+ (p=0.196) (Supplementary Figures 1A–C). The gene discussed is CD4; the disease is systemic lupus erythematosus.